FUS and proteostasis deficiencies: Moreover, HSP60 signaling pathway may be critical for FUS-induced neurotoxicity, and reducing HSP60 expression or suppressing HSP60 activity may provide therapeutic benefit for FUS-proteinopathies patients with increased HSP60 expression.